ClinicalTrials.govpublic full text
HEALEY ALS Platform Trial - Regimen G DNL343
amyotrophic lateral sclerosis, als, placebo-controlled, double-blind, regimen specific appendix, lou gehrig's disease, dnl343, denali therapeutics, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 805739
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.